Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40
Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
Health Care M&A Deals, Week Ending February 7, 2020
The Health Care M&A Weekly chart is a selection of transactions announced during the prior week(s). The deals presented here are from our Deal Search Online database, which is updated every business day. Visit www.dealsearchonline.com to see how Deal Search Online can help you stay up-to-date on the healthcare market overall, or in a particular sector of interest to your firm. Behavioral Health Care Acquirer Target Price The Emily Program Eating disorder treatment program N/A eHealth Acquirer Target Price Innoval Global Solutions, LLC Medstat N/A Hospitals Acquirer Target Price UPMC Western Maryland Health System N/A Christus Santa Rosa Health System Central Texas... Read More »
Feeling Distressed? You’re Not Alone
For the past two years, the volume of healthcare deals has soared to new heights. Much of the growth has been powered by financial buyers, private equity firms in particular, piling into the healthcare services sectors. In 2018, a new record for annual deal volume was hit, now standing at 1,917. The services sectors accounted for 65% (1,242 deals), slightly higher than the typical 60% to 62%. Last year’s total deal tally now stands at 1,824 transactions, the second highest total ever recorded, and 70% of that comes from healthcare services deals. Why, then, have Chapter 11 bankruptcy filings among the services sectors spiked along with that activity? Since the second quarter of 2017, the... Read More »
Digital Health Roars out of the Gate
The eHealth sector had a record 2019, with 222 deals now on the books, a roughly 9% increase over 2018’s volume, and $18.3 billion in spending. That momentum has carried over to the first month of 2020, with 19 eHealth deals in January and $1.8 billion in announced spending, according to our Deal Search Online database. January was capped off by Clarivate Analytics plc’s (NYSE: CCC) acquisition of Decision Resources Group (DRG) from Piramal Enterprises Limited (NSE: PEL) The purchase cost Clarivate Analytics $900 million in cash and $50 million in shares. DRG provides analytics and insights, driven by artificial intelligence (AI), to the pharmaceutical, biotechnology and life sciences... Read More »
Fourth Quarter Momentum Carries over to January
It’s a new year, a new decade, and not much has changed in healthcare mergers and acquisitions. January was a strong month for deal flow, which isn’t unusual because deals that didn’t close in December often spill over into the following month, which just happens to launch a new fiscal cycle, for many entities. January 2020 opened with a strong showing for deal volume. At this writing, 132 deal are in our database and we’ll be adding more as earnings reports and other documents come to light. Looking back at December, we now have 168 deals on the books, as more Long-Term Care, Physician Medical Group and other transactions came to light. So the fourth quarter of 2019 finished in grand... Read More »
Aveanna Healthcare Calls Off Maxim Home Health Merger
The Federal Trade Commission has done it again. The agency closed its investigation into the merger of Aveanna Healthcare with Maxim Healthcare’s home health division, announced in February 2019. We’re accustomed to seeing headlines every few months saying the FTC plans to tighten scrutiny of hospital mergers and acquisitions. The anti-trust division has been active in the hospital sector, the majority of announced hospital mergers more often collapse under their own, unique conditions. Just last year, Care New England ended merger talks with Lifespan and Brown University, after seeing its merger with Boston’s Partners HealthCare shot down by Rhode Island’s... Read More »
Catalent acquires MaSTherCell Global
Catalent, Inc. (NYSE: CTLT) announced a $315 million deal for MaSTherCell Global, a technology-focused cell and gene therapy contract development and manufacturing organization based in Gosselies, Belgium. It is backed by Great Point Partners, SFPI-FPIM (the Belgian Federal Holdings and Investment Company) and Orgenesis Inc. (NASDAQ: ORGS). This is the Somerset, New Jersey-based CRO’s fifth deal since 2014, all of them for domestic targets, according to search results in our Healthcare Deals Database. Its most recent one was announced in April 2019, for Baltimore-based Paragon Bioservices, Inc., a contract research organization, for $1.2 billion. Founded in 2011, MaSTherCell has a... Read More »
Saga Continues for St. Christopher’s Hospital for Children
Where there’s a hospital or health system filing for bankruptcy protection, there’s usually a sale in the offing that involves a real estate investment trust. That’s the most recent twist in the story of St. Christopher’s Hospital for Children, which we first reported in September 2019. The 188-bed hospital, a critical safety-net hospital for children in North Philadelphia, and Hahnemann University Hospital were sold in September 2018 to California investment banker Joel Freedman, head of American Academic Health System, LLC (AAHS), for $170 million. Hahnemann’s financial troubles prompted Freedman to file for Chapter 11 bankruptcy protection for both hospitals on... Read More »
Quest Acquires Memorial Hermann Outreach Labs
Quest Diagnostics (NYSE: DGX) has had a busy month. On January 22, it acquired Blueprint Genetics, a leading genetic testing company based in Helsinki, Finland, for an undisclosed amount. Now, it’s turned its sites back home. On January 27, it announced a deal for substantially all of the Memorial Hermann Diagnostic Laboratories (MDHL), the outreach lab division of not-for-profit Memorial Hermann Health System in Houston. Memorial Hermann has 17 hospitals and more than 300 care delivery sites in the greater Houston area. The acquisition includes nearly 30 MHDL patient service centers and nearly 60 in-office laboratory service sites. These services will transition to the Quest... Read More »
Health Care M&A Deals, Week Ending January 31, 2020
The Health Care M&A Weekly chart is a selection of transactions announced during the prior week(s). The deals presented here are from our Deal Search Online database, which is updated every business day. Visit www.dealsearchonline.com to see how Deal Search Online can help you stay up-to-date on the healthcare market overall, or in a particular sector of interest to your firm. Biotechnology Acquirer Target Price AstraZeneca plc Global rights to brazikumab N/A Home Health Care & Hospice Acquirer Target Price Eden Health Legacy Home Healthcare N/A Pharmaceuticals Acquirer Target Price Nestle SA Zenpep and Viokace N/A Atnahs Pharma Rights to hypertension... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
